Prospective Observational Study to Identify Factors Influencing Adverse Symptoms Associated With Endocrine Therapy in Breast Cancer Patients, a Protocol: Contribution of Japanese Traditional Medicine to Quality of Life and Work Productivity

ABSTRACT Aim Endocrine therapy causes side effects ( SEs ) such as hot flushes, joint stiffness, and psychological disorders in patients with breast cancer ( BC ). To address these symptoms, Japanese traditional (Kampo) medicine will be used as treatment. This study aims to identify factors that influence the SE associated with endocrine therapy in patients with BC and evaluate an association with symptom relief of Kampo medicine in alleviating the SE . Methods A prospective observational study will be conducted from May 1, 2024 to March 31, 2027, including patients aged > 20 years with BC (clinical stages 0 to III ) experiencing SE from endocrine therapy. The SE will be rated on a numerical rating scale ( NRS ) from 0 (no symptom) to 10 (worst symptom). Treatment with Kampo or conventional medicines will depend on the patient preference. Prescriptions will be designed to suit patient's symptoms and physical findings, following the principles of Kampo medicine. Data on the patient's background, physical examination, routine clinical examination, and medication will be collected. The assessment—including symptom severity by NRS , quality of life ( QOL ) by EuroQol 5 dimensions 5‐level ( EQ ‐ 5D ‐ 5L ) and Functional Assessment of Cancer Therapy‐Breast ( FACT ‐B), and work productivity and activity impairment by the Work Productivity and Activity Impairment‐General Health ( WPAI ‐ GH )—will be conducted using an electronic patient‐reported outcome system. This study protocol has been approved by the Ethics Committee of our university. Conclusion By demonstrating an association with symptom relief of Kampo medicine in managing SEs of endocrine therapy for BC, this study aims to improve patients' QOL and work productivity. Trial Registration: This study was registered in the University Hospital Medical Information Network Center (UMIN000054353)

Authors

Institutions

Publication Details

Journal
Traditional & Kampo Medicine
Published
2025-10-02
DOI
https://doi.org/10.1002/tkm2.70020
Citations
1
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective Observational Study to Identify Factors Influencing Adverse Symptoms Associated With Endocrine Therapy in Breast Cancer Patients, a Protocol: Contribution of Japanese Traditional Medicine to Quality of Life and Work Productivity

Ryutaro Arita, Takanori Ishida, Haruhiko Shindo, Hiroshi Tada et al.
1 citations
Traditional & Kampo Medicine
Cancer Treatment and Pharmacology
1.05
article

Prospective Observational Study to Identify Factors Influencing Adverse Symptoms Associated With Endocrine Therapy in Breast Cancer Patients, a Protocol: Contribution of Japanese Traditional Medicine to Quality of Life and Work Productivity

Ryutaro Arita, Takanori Ishida, Haruhiko Shindo, Hiroshi Tada, Shih‐Wei Chiu, Akiko Kikuchi, Natsumi Saito, Rie Ono, Minoru Miyashita, Tadashi Ishii, Shin Takayama, Akihiko Furuta, Yosuke Kawabe, Kaolu Sato
article en
1 citations

Abstract

ABSTRACT Aim Endocrine therapy causes side effects ( SEs ) such as hot flushes, joint stiffness, and psychological disorders in patients with breast cancer ( BC ). To address these symptoms, Japanese traditional (Kampo) medicine will be used as treatment. This study aims to identify factors that influence the SE associated with endocrine therapy in patients with BC and evaluate an association with symptom relief of Kampo medicine in alleviating the SE . Methods A prospective observational study will be conducted from May 1, 2024 to March 31, 2027, including patients aged > 20 years with BC (clinical stages 0 to III ) experiencing SE from endocrine therapy. The SE will be rated on a numerical rating scale ( NRS ) from 0 (no symptom) to 10 (worst symptom). Treatment with Kampo or conventional medicines will depend on the patient preference. Prescriptions will be designed to suit patient's symptoms and physical findings, following the principles of Kampo medicine. Data on the patient's background, physical examination, routine clinical examination, and medication will be collected. The assessment—including symptom severity by NRS , quality of life ( QOL ) by EuroQol 5 dimensions 5‐level ( EQ ‐ 5D ‐ 5L ) and Functional Assessment of Cancer Therapy‐Breast ( FACT ‐B), and work productivity and activity impairment by the Work Productivity and Activity Impairment‐General Health ( WPAI ‐ GH )—will be conducted using an electronic patient‐reported outcome system. This study protocol has been approved by the Ethics Committee of our university. Conclusion By demonstrating an association with symptom relief of Kampo medicine in managing SEs of endocrine therapy for BC, this study aims to improve patients' QOL and work productivity. Trial Registration: This study was registered in the University Hospital Medical Information Network Center (UMIN000054353)

Traditional & Kampo MedicineVol. 12(3)
Tohoku University (JP), Ishinomaki Senshu University (JP), Tohoku University Hospital (JP)
Tsumura and Company
Openalex Percentile: Top 17%
Cancer Treatment and Pharmacology
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.